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217 GLOBAL GENE EXPRESSION PROFILING OF EARLY
OSTEOARTHRITIS IN WILD-TYPE MICE AND MICE LACKING
ADAMTS-5 ACTIVITY
D. Belluoccio1, L. Rowley1, A. Fosang1, C. Little2, J.F. Bateman1.
1Murdoch Childrens Research Institute, Parkville, AUSTRALIA,
2University of Sydney, Sydney, AUSTRALIA
Purpose: To explore the molecular mechanisms of osteoarthritis (OA)
initiation and progression, global gene expression proﬁling was performed
on cartilage from mice with surgically-induced OA. We used WT mice,
and mice lacking ADAMTS-5 activity (ADAMTS-5 Dcat). By comparing
the gene expression during OA in these mice we have distinguished early
events leading to aggrecan degradation (pre-ﬁbrillated changes) from the
downstream progressive phases that follow loss of aggrecan.
Methods: Mechanical instability was introduced into 10 week old male
mouse knee joints by surgical destabilization of the medial meniscus
(DMM). In this model focal degeneration, exempliﬁed by loss of aggrecan
in the non-calciﬁed articular cartilage, occurs in the medial tibial plateau
2 weeks after surgery in WT mice. After 6 weeks, aggrecan loss had
progressed and cartilage ﬁbrillation was evident. In ADAMTS-5 Dcat
mice aggrecan loss and cartilage erosion is signiﬁcantly reduced. Non-
calciﬁed cartilage from the developing lesion in DMM or sham-operated
joints at 1, 2 and 6 weeks post-surgery was harvested by laser microdis-
section. Chondrocyte total RNA was extracted and cRNA generated by
linear ampliﬁcation (MessageAmp, Ambion), labeled with Cy3/Cy5 and
hybridized to 44k whole genome microarrays (Agilent). Data was validated
by quantitative PCR of selected genes.
Results: There was an early upregulation (1 week) in WT mice of carti-
lage hypertrophy markers, such as collagen X. However in the ADAMTS-5
Dcat mice, these were not upregulated until 6 weeks, suggesting that
the hypertrophic response of chondrocytes is not an initiating event,
but an event downstream of the onset of ADAMTS-5 activity and/or
cartilage degeneration. Of particular interest was the upregulation of
the inﬂammatory mediator Ptgs2 (Cox-2) early (1 and 2 weeks) in WT
OA mice. Upregulation of Cox-2 was not seen in ADAMTS-5 Dcat mice.
Dysregulation of several Bmps (eg Bmp7), inﬂammatory cytokines, Fgfs,
members of the Wnt/b-catenin pathway were apparent in WT mice.
Expression proﬁling also showed numerous changes in gene expression
that followed the same pattern in both WT and ADAMTS-5 Dcat mice,
and thus are likely to be independent of ADAMTS-5-mediated aggrecan
degradation. These changes include upregulation of several cathepsins
(eg cathepsin S), Bmps (eg Bmp7) lumican and ﬁbronectin.
Conclusions: This well controlled OA model combined with precise
microdissection of cartilage from developing cartilage lesions and mi-
croarray technology provides new insights into gene expressed during
the initiation and progression of OA. Furthermore the comparison of OA
gene expression in WT, ADAMTS-5 Dcat and other mouse models will
allow us to prioritize candidate genes for functional analysis.
218 GENOME-WIDE COMPARATIVE TRANSCRIPTOME ANALYSIS
OF CARTILAGE FORMATION IN VIVO
T.L. Cameron1, D. Belluoccio1, B. Brachvogel2, P.G. Farlie1,
J.F. Bateman1. 1Murdoch Childrens Research Institute, Parkville,
AUSTRALIA, 2University of Cologne, Cologne, GERMANY
Purpose: The regulation of in vivo chondrogenesis is incompletely un-
derstood, and would be informed by comprehensive analyses of gene
expression. So far however, this goal has been limited by an inability
to access RNA of sufﬁcient quality from in vivo chondrogenic tissues.
In the present study, we set out to generate gene expression proﬁles
representative of key stages of in vivo chondrogenesis.
Methods: Tibial and ﬁbular pre-condensed mesenchyme from 11.5dpc
Swiss White mouse hindlimbs and the corresponding condensations and
cartilage anlagen from 12.5dpc and 13.5dpc mice were micodissected
and total RNA isolated using TRIzol. cRNA was generated by linear
ampliﬁcation (MessageAmp, Ambion), labeled with Cy3 or Cy5 and
hybridized to 44k whole genome oligo microarrays (Agilent). Microarray
data was validated by quantitative PCR of selected genes.
Results: We found signiﬁcant differential expression of 931 genes during
these early stages of chondrogenesis. Of these, 380 genes were down-
regulated and 551 up-regulated. Our studies characterized the expres-
sion pattern of gene families previously associated with chondrogenesis,
such as adhesion molecules, secreted signalling molecules, transcription
factors and extracellular matrix components. Gene ontology approaches
identiﬁed 892 differentially expressed genes not previously identiﬁed
during the initiation of chondrogenesis. These included several Bmp, Gdf,
Wnt, Sox, Fox, Lhx, Robo and Slit family members.
Conclusions: These data represent the ﬁrst global gene expression pro-
ﬁling analysis of chondrogenic tissues during in vivo development. They
identify genes for further study on their functional roles in chondrogenesis,
and provide a comprehensive and important resource for future studies
on cartilage development, disease, and repair.
219 PHASE II ENZYME INDUCER SULFORAPHANE BLOCKS
CATABOLIC PATHWAY IN ARTICULAR CHONDROCYTES
AND INHIBITS MONOIODOACETATE INDUCED
OSTEOARTHRITIS IN RATS
H.A. Kim1, C-K. Chung2, Y. Yeo1, S. Kim1, I. Kim1. 1Hallym University
Sacred Heart Hospital, Anyang, REPUBLIC OF KOREA, 2Seoul
National University Hospital, Seoul, REPUBLIC OF KOREA
Purpose: Phase 2 enzyme inducers are recently found to have anti-
inﬂammatory activity in addition to its chemopreventive activity. In the
current study, we examined the inﬂuence of sulforaphan (SFN), one of
the most potent inducer of the phase 2 enzymes on the induction of
nitric oxide (NO) and prostaglandin (PG) E2 in human articular chondro-
cytes. The efﬁcacy of SFN on an animal model of osteoarthritis (OA),
monoiodoacetate (MIA) induced arthritis in rats was also examined.
Methods: Articular cartilages were obtained from knee OA patients and
cultured in monolayer. Chondrocytes were stimulated with interleukin
(IL)-1 or tumor necrosis factor (TNF)-a with or without 1 hour pre-
incubation with SFN. Production of NO and PGE2 was evaluated by
Greiss reaction and enzyme linked immunosorbent assay (ELISA), re-
spectively. The expression of inducible NO synthase and cyclooxygenase
(COX)-2 was evaluated by real time reverse transcriptase-polymerase
chain reaction and Western blot. Knee joints of rats were injected with
3mg of MIA and 10mM of SFN was injected biweekly. The severity of
arthritis was evaluated after 1 and 2 weeks by histological grading of
articular cartilage in SFN-treated and control animals.
Results: SFN signiﬁcantly inhibited the production of NO and PGE2
induced by either Il-1 or TNF-a dose dependently in monolayer cultured
chondrocytes. At the concentration of 10 mM, SFN completely inhibited
both NO and COX-2 at mRNA and protein level. SFN treated rats showed
signiﬁcant inhibition of cartilage degradation at 1 week after MIA injection,
but at 2 weeks, the difference was not signiﬁcant between SFN-treated
and control rats
Conclusions: SFN was found to inhibit NO and PGE2 production
in proinﬂammatory cytokine stimulated chondrocytes and MIA induced
rat OA. Delineation of biochemical mechanism regulating cartilage
catabolism by SFN may identify potentially safe and effective therapeutic
target for inhibition of cartilage degradation in arthritic diseases.
220 EFFECT OF ETANERCEPT ON iNOS, Il-6, AND COX-2 GENE
EXPRESSION IN HUMAN CHONDROCYTES IN VITRO
C. Valvason Jr1, E. Musacchio2, A. Pozzuoli3, A. Gava1, R. Ramonda1,
A. Lo Nigro1, L. Sartori2, R. Aldegheri3, L. Punzi1. 1Rheumatology Unit,
Department of Clinical and Experimental Medicine, University of Padova,
Padova, ITALY , 2Clinica Medica I, Department of Medical and Surgical
Sciences, University of Padova, Padova, ITALY, 3Orthopaedic Clinic,
Department of Medical and Surgical Specialties, University of Padova,
Padova, ITALY
Purpose: Erosive osteoarthritis (EOA) is considered as an aggressive
variant of hand OA characterized by a prominent local inﬂammation and
radiographic aspects of central bone erosion on interphalangeal joints.
Cytokines, such as Interleukin (IL)-1b and Tumor Necrosis Factor (TNF)-
a, are involved in the pathophysiology of OA, directly and by stimulation of
synoviocytes and chondrocytes to produce inﬂammatory molecules like
nitric oxide (NO), Il-6 and cyclooxygenase (COX)-2. In inﬂamed joints,
NO is involved in joint destruction by enhancing cytokine production and
suppressing collagen and proteoglycan synthesis while Il-6 is implicated
in bone erosion. Moreover, COX-2 could indirectly affect chondrocytes
metabolism by the production of prostaglandins that mediate pain, sup-
port the inﬂammatory process and inhibit aggrecan synthesis.
The aim of the present study was to investigate the effects of the TNFa-
antagonist etanercept on Il-6, COX-2 and iNOS gene expression in human
chondrocytes
Methods: Primary human chondrocytes were obtained from non-weight
bearing articular cartilage of femoral heads after sequential digestions
with trypsin and collagenase. Chondrocytes were treated with different
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concentrations of human recombinant Il-1b (5 ng/ml) and TNFa (20 or
40 ng/ml) and simultaneously with etanercept at 100mg/ml for 24 hours;
gene expression of iNOS Il-6, and COX-2 and was assessed by the
RT/PCR method using 18S rRNA as the housekeeping gene.
Results: Etanercept determined a complete suppression of TNFa-
induced iNOS, Il-6, and COX-2 gene expression. This anti-TNFa drug
also downregulated, with a dose-dependent effect, iNOS and COX-2 gene
expression (−20% and −30% respectively, p< 0.05) after stimulation with
Il-1b. Etanercept seemed to have no effects on Il-1b-induced Il-6 gene
expression.
Conclusions: To our knowledge, this is the ﬁrst report of the effects of
etanercept on iNOS, Il-6 and COX-2 gene expression, after inﬂammatory
stimulation, on a human chondrocyte population. In summary, these data
suggest that the beneﬁcial effects of the treatment with etanecerpt in EOA
could be further explained by the action of this biological drug at cartilage
level.
221 COLLAGEN TYPE IX AND CARTILAGE OLIGOMERIC MATRIX
PROTEIN INFLUENCE CARTILAGE MATRIX ASSEMBLY
Y.M. Bastiaansen-Jenniskens1, K. Blumbach2, W. Koevoet1,
M. Paulsson2, J. DeGroot3, F. Zaucke2, G.J. van Osch1. 1Erasmus
MC, University Medical Center, Rotterdam, NETHERLANDS, 2Medical
Faculty, University of Cologne, Cologne, GERMANY, 3Business Unit
BioSciences, TNO Quality of Life, Leiden, NETHERLANDS
Purpose: Collagen type IX (COL9) and Cartilage Oligomeric Matrix
Protein (COMP) are proteins present in the cartilage matrix. Even though
there is clear evidence that these cartilage matrix proteins interact with
each other and collagen type II, their exact function in matrix organisation
is not yet completely understood. In early osteoarthritic cartilage, collagen
type II expression is increased but repair is ineffective. Other matrix
components such as COL9 and COMP are possibly required for the
formation of the collagen ﬁbrils and the structure and integrity of the
network. To get more insight into these requirements and investigate
them as possible targets for matrix regeneration, we investigated the role
of COMP and collagen type IX in cartilage matrix production.
Methods: Chondrocytes isolated from mice deﬁcient in COL9 and COMP
(double knock-out, DKO), COL9 alone (Col9−/−) and wild type (WT) mice
were cultured for ﬁve weeks in alginate beads. Collagen cross-linking
(speciﬁcally the HP cross-links), glycosaminoglycan (GAG) and collagen
deposition and distribution over cell-associated, further-removed matrix,
and culture medium were determined.
Results: In both knock-out conditions, less GAG was deposited than
in the WT condition: 10.2±0.3mg GAG/bead in the WT condition,
5.9±0.1mg/bead in Col9−/− and 6.4±2.9 mg/bead in the DKO condition.
Collagen deposition was only less in Col9−/−: 6.3±0.9mg collagen/bead
in the WT condition versus 3.9±0.4mg/bead in Col9−/−. The absence of
COL9 and COMP differentially inﬂuenced collagen and GAG retention
and distribution within the alginate bead. In both knock-out conditions,
less GAG and collagen was present in the cell associated matrix (CM)
than in the control condition. GAG and collagen distributed differentially
over the further removed matrix (FRM) and the culture medium (Figure 1).
In addition, the deposited collagen was less cross-linked in both knock-
out conditions: 0.52±0.02 HP/collagen in the control condition, 0.39±0.01
HP/collagen in Col9−/− and 0.43±0.00 HP/collagen in DKO.
Figure 1: Distribution of extracellular matrix components between the cell
associated matrix (CM, black), further removed matrix (FRM, light grey)
and the culture medium (white) in cultures of cells deﬁcient for COL9 or
COL9 and COMP (dko). The bars represent the absolute quantity with
the relative distribution shown as percentages.
Conclusions: COL9 and COL9/COMP deﬁciency resulted in less carti-
lage matrix deposition and altered distribution, suggesting that the effects
seen are a result of COL9 deﬁciency. COMP deﬁciency in addition does
not change the effect seen with single COL9 knockout. COL9 seems more
important in the formation of a functional cartilage matrix than COMP and
might therefore be a target in cartilage regeneration.
222 NITRIC OXIDE (NO) IN SOME CONDITIONS INDUCES
AUTOPHAGY IN HUMAN ARTICULAR CHONDROCYTES
M.C. De Andre´s, F. Galdo, F.J. Blanco. Osteoarticular and Aging
Research Laboratory. Rheumatology Division. Biomedical Research
Center INIBIC – Hospital Universitario Juan Canalejo, Corun˜a, SPAIN
Purpose: Nitric Oxide (NO) is a short-lived and multifunctional molecule
that mediates various biological processes. Osteoarthritis disease (OA)
is characterized by an increase in both chondrocyte death (apoptosis)
and NO production; in fact, OA cells produce as much, if not more, NO
than any other cell in the body. Different studies have shown up until
now that programmed cell death is not necessarily synonymous with
apoptosis. It has been described that in the growth plate of cartilage,
stress conditions can promote an autophagic response in chondrocytes,
through the regulation of genes controlling metabolite utilization. Besides
serving a cytoprotective role, it is known that autophagy can function in
cell death. Articular cartilage shows per se hostile conditions so it is an
avascular tissue and possesses low O2 tensions.
Objective: To study the induction of autophagic features in normal and
OA human chondrocytes by NO.
Methods: Normal and OA human cartilages were obtained from patients
with joint replacement (femoral and knee joint) and from autopsy cases
(knee joint). After enzimatic digestion, chondrocytes were kept in DMEM
with 10% SBF at 37ºC in a humidiﬁed atmosphere provided by an incu-
bator until the ﬁrst subculture was reached. Normal, OA and NO donors
(SNP and NOC-12) treated normal cells were analyzed by ﬂow cytometry
to quantify the apoptosis by means of propidium iodide and BRDU
methods. On the other hand, the expression of two AuTophaGy-related
(ATG) genes, Beclin-1 and APG-7, was assessed by means of western-
blot, immunocytochemistry and ﬂow cytometry, using speciﬁc monoclonal
antibodies (Abcam, UK). Besides, we analyzed the b-galactosidase (an
enzyme linked to lysosome) activity in cells by means of a commercial
kit (BioVision, Inc).
Results: Previous results obtained by us showed that normal and OA
chondrocytes show morphologic changes more characteristic of au-
tophagocytosis than apoptosis. Direct observation with optic microscopy
of chondrocytes treated with NO donors stated the remarkable morpho-
logical differences between SNP induced effects (apoptotic typical mor-
phology) and NOC-12 induced effects (apparition of striking cytoplasmatic
vacuoles). Results obtained by means of ﬂow cytometry, both using the
propidium iodide method as well as the highly speciﬁc BRDU method,
showed us that apoptotic cell percentage induced by classic NO donor
SNP (~45%) is much higher than the percentage observed with NOC-
12 (~11%). The study of Beclin-1 expression by means of western-blot
showed us that in a signiﬁcant way OA chondrocytes have a 1.7 ratio in
the expression of this protein with respect to the normal cells, ﬁndings
were corroborated with an immunocytochemistry study; however, APG-7
levels were similar between normal and OA chondrocytes, although we
could observe that the latter ones show a crescent tendency in its
expression by means of ﬂow cytometry. On the other hand, both NOC-12
and SNP treated chondrocytes show Beclin-1 and APG-7 expression. We
observed b-galactosidase activity in all cases.
Conclusions: These results show that, besides apoptosis, programmed
cell death-Type II is important to human articular chondrocytes. The
presence of autophagic levels in human chondrocytes, suggest to us
a response that can permit the terminally differentiated cells to survive
the brief rigors of the harsh local microenvironment that exists in human
cartilage, all above in OA cartilage.
223 EFFICIENT NON-VIRAL TRANSFECTION OF
PRIMARY HUMAN ADULT CHONDROCYTES AND
CHONDROCYTE-DERIVED CELL LINES IN A
HIGH-THROUGHPUT FORMAT
J. Haag, S. Soeder, T. Aigner. Institut fuer Pathologie, Leipzig,
GERMANY
Purpose: The in vitro transfer of plasmid DNA or siRNA constructs
into cells provides a powerful tool for the analysis of basic cellular and
